High‐level expression of Hsp90β is associated with poor survival in resectable non‐small‐cell lung cancer patients

By  

HISTOPATHOLOGY, Vol. 67, Iss. 4, 2015-10 ,pp. : 509-519

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical Phase II Trial of Treosulfan in Patients with Non-Resectable Non-Small-Cell Lung Cancer

By  

Oncology Research and Treatment, Vol. 21, Iss. 4, 1998-09 ,pp. : 316-319

Karger

Access to resources Recommend Favorite

SIRT6 expression is associated with poor prognosis and chemosensitivity in patients with non‐small cell lung cancer

By  

JOURNAL OF SURGICAL ONCOLOGY, Vol. 112, Iss. 2, 2015-08 ,pp. : 231-237

John Wiley & Sons Inc

Access to resources Recommend Favorite

Decreased expression of miR-204 in plasma is associated with a poor prognosis in patients with non-small cell lung cancer

By              

International Journal of Molecular Medicine, Vol. 36, Iss. 6, 2015-01 ,pp. : 1720-1726

Spandidos Publications

Access to resources Recommend Favorite

14-3-3ζ Overexpression and abnormal β-catenin expression are associated with poor differentiation and progression in stage I non-small cell lung cancer

By Zang Dongyu   Li Xiaoming   Zhang Lin  

Clinical and Experimental Medicine, Vol. 10, Iss. 4, 2010-12 ,pp. : 221-228

Springer Publishing Company

Access to resources Recommend Favorite